Mapping suitability for Buruli ulcer at fine spatial scales across Africa: A modelling study.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
03 2021
Historique:
received: 22 04 2020
accepted: 17 01 2021
revised: 15 03 2021
pubmed: 4 3 2021
medline: 25 6 2021
entrez: 3 3 2021
Statut: epublish

Résumé

Buruli ulcer (BU) is a disabling and stigmatising neglected tropical disease (NTD). Its distribution and burden are unknown because of underdiagnosis and underreporting. It is caused by Mycobacterium ulcerans, an environmental pathogen whose environmental niche and transmission routes are not fully understood. The main control strategy is active surveillance to promote early treatment and thus limit morbidity, but these activities are mostly restricted to well-known endemic areas. A better understanding of environmental suitability for the bacterium and disease could inform targeted surveillance, and advance understanding of the ecology and burden of BU. We used previously compiled point-level datasets of BU and M. ulcerans occurrence, evidence for BU occurrence within national and sub-national areas, and a suite of relevant environmental covariates in a distribution modelling framework. We fitted relationships between BU and M. ulcerans occurrence and environmental predictors by applying regression and machine learning based algorithms, combined in an ensemble model to characterise the optimal ecological niche for the disease and bacterium across Africa at a resolution of 5km x 5km. Proximity to waterbodies was the strongest predictor of suitability for BU, followed potential evapotranspiration. The strongest predictors of suitability for M. ulcerans were deforestation and potential evapotranspiration. We identified patchy foci of suitability throughout West and Central Africa, including areas with no previous evidence of the disease. Predicted suitability for M. ulcerans was wider but overlapping with that of BU. The estimated population living in areas predicted suitable for the bacterium and disease was 46.1 million. These maps could be used to inform burden estimations and case searches which would generate a more complete understanding of the spatial distribution of BU in Africa, and may guide control programmes to identify cases beyond the well-known endemic areas.

Identifiants

pubmed: 33657104
doi: 10.1371/journal.pntd.0009157
pii: PNTD-D-20-00668
pmc: PMC7959670
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0009157

Subventions

Organisme : Medical Research Council
ID : MR/J01477X/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Am J Trop Med Hyg. 2016 Jul 6;95(1):63-9
pubmed: 27185767
Lancet Glob Health. 2014 Jul;2(7):e422-30
pubmed: 25103396
PLoS One. 2012;7(12):e51074
pubmed: 23251425
Int J Mycobacteriol. 2014 Jun;3(2):158-61
pubmed: 26786340
Lancet Infect Dis. 2015 Aug;15(8):968-80
pubmed: 26049967
Infect Ecol Epidemiol. 2013;3:
pubmed: 23440849
PLoS Negl Trop Dis. 2010 Dec 14;4(12):e911
pubmed: 21179505
Microb Ecol. 2017 Aug;74(2):350-361
pubmed: 28238016
PLoS Negl Trop Dis. 2014 Jan 30;8(1):e2668
pubmed: 24498452
Curr Trop Med Rep. 2018;5(4):247-256
pubmed: 30460172
PLoS Negl Trop Dis. 2019 Apr 15;13(4):e0007317
pubmed: 30986205
Ecohealth. 2014 Jun;11(2):184-96
pubmed: 24442959
Am J Trop Med Hyg. 1995 Mar;52(3):219-24
pubmed: 7694962
Lancet Planet Health. 2017 May;1(2):e65-e73
pubmed: 29851583
Trans R Soc Trop Med Hyg. 2008 Oct;102(10):969-78
pubmed: 18657836
Ecol Appl. 2009 Jan;19(1):181-97
pubmed: 19323182
PLoS Negl Trop Dis. 2012 Jan;6(1):e1506
pubmed: 22303498
Lancet. 2020 Apr 18;395(10232):1259-1267
pubmed: 32171422
BMC Health Serv Res. 2013 Dec 05;13:507
pubmed: 24313975
Emerg Infect Dis. 2019 Mar;25(3):600-601
pubmed: 30789331
Parasit Vectors. 2018 Sep 6;11(1):501
pubmed: 30189883
J Travel Med. 2021 Jan 6;28(1):
pubmed: 33063113
Environ Int. 2006 May;32(4):567-73
pubmed: 16492390
Int J Epidemiol. 1973 Summer;2(2):161-5
pubmed: 4777772
Appl Environ Microbiol. 2016 Jun 30;82(14):4320-4329
pubmed: 27208141
PLoS Negl Trop Dis. 2018 Jul 2;12(7):e0006572
pubmed: 29965961
Emerg Infect Dis. 2015 Aug;21(8):1414-7
pubmed: 26196525
PLoS Negl Trop Dis. 2018 Mar 1;12(3):e0006324
pubmed: 29494642
Clin Dermatol. 2009 May-Jun;27(3):291-305
pubmed: 19362692
Am J Trop Med Hyg. 2004 May;70(5):520-6
pubmed: 15155984
Bull Acad Natl Med. 2012 Mar;196(3):685-90; discussion 690-1
pubmed: 23472356
Br Med J. 1970 May 16;2(5706):390-3
pubmed: 5420605
Clin Infect Dis. 2005 May 15;40(10):1445-53
pubmed: 15844067
FEMS Microbiol Lett. 2008 Oct;287(2):250-5
pubmed: 18754785
PLoS Negl Trop Dis. 2010 Jul 20;4(7):e751
pubmed: 20652033
PLoS Negl Trop Dis. 2014 May 15;8(5):e2879
pubmed: 24831924
Int J Infect Dis. 2019 Dec;89:128-130
pubmed: 31585214
Lancet Glob Health. 2019 Jul;7(7):e912-e922
pubmed: 31200890
J Bacteriol. 2005 Mar;187(5):1639-47
pubmed: 15716434
PLoS Negl Trop Dis. 2008 Jul 30;2(7):e271
pubmed: 18665259
PLoS Negl Trop Dis. 2008 Mar 26;2(3):e205
pubmed: 18365034
Bull Soc Pathol Exot. 2001 Mar;94(1):46-51
pubmed: 11346983
Am J Trop Med Hyg. 2004 Oct;71(4):387-92
pubmed: 15516631
Emerg Infect Dis. 2002 Feb;8(2):167-70
pubmed: 11897068
Sci Data. 2018 Oct 30;5:180214
pubmed: 30375988
Appl Environ Microbiol. 2007 Aug;73(15):4733-40
pubmed: 17526786
Med Sci (Paris). 2007 Jun-Jul;23(6-7):572-5
pubmed: 17631825
PLoS Negl Trop Dis. 2015 Jun 19;9(6):e0003840
pubmed: 26091265
Int Health. 2017 Jan;9(1):36-43
pubmed: 27986841
Med Sante Trop. 2013 Oct-Dec;23(4):450-7
pubmed: 24413612
Lancet Glob Health. 2014 Nov;2(11):e629
pubmed: 25442683
PLoS Negl Trop Dis. 2015 Oct 16;9(10):e0004123
pubmed: 26474482
Acta Trop. 2017 Nov;175:138-144
pubmed: 28034768
Ecohealth. 2014 Jun;11(2):168-83
pubmed: 24306551
PLoS Negl Trop Dis. 2010 Aug 10;4(8):e791
pubmed: 20706592
Int J Health Geogr. 2019 Nov 6;18(1):23
pubmed: 31694656
Sante Publique. 2005 Jun;17(2):191-7
pubmed: 16001561
Int J Health Geogr. 2014 Oct 25;13:44
pubmed: 25344052
Trends Ecol Evol. 2019 Jul;34(7):655-668
pubmed: 31078330

Auteurs

Hope Simpson (H)

London School of Hygiene and Tropical Medicine, London, United Kingdom.

Earnest Njih Tabah (EN)

National Yaws, Leishmaniasis, Leprosy and Buruli ulcer Control Programme, Cameroon.

Richard O Phillips (RO)

School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Michael Frimpong (M)

School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Issaka Maman (I)

National Reference Laboratory for Buruli Ulcer Disease in Togo, Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), Laboratoire des Sciences Biologiques et des Substances Bioactives, Université de Lomé, Lomé, Togo.

Edwin Ampadu (E)

National Buruli Ulcer Control Program, Ghana Health Service, Accra, Ghana.

Joseph Timothy (J)

London School of Hygiene and Tropical Medicine, London, United Kingdom.

Paul Saunderson (P)

Accelerating Integrated Management (AIM) Initiative, Accra, Ghana.

Rachel L Pullan (RL)

London School of Hygiene and Tropical Medicine, London, United Kingdom.

Jorge Cano (J)

London School of Hygiene and Tropical Medicine, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH